news-details

WHO says vaccine investment key to combat antimicrobial resistance

A new report by the World Health Organisation (WHO) has identified that increased vaccine investment could avert deaths due to antimicrobial resistance (AMR).

The report outlines how vaccines could reduce the number of antibiotics needed by 22 per cent or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR).

AMR occurs when bacteria, viruses, fungi and parasites change and no longer respond to the medicines designed to kill them, making infections more difficult to treat. It is driven largely by the misuse and overuse of antimicrobial drugs.

According to WHO, AMR is the third leading cause of mortality in the world, with over one million deaths directly linked to bacterial AMR, and five million deaths indirectly.

WHO projected that AMR will cause 39 million deaths worldwide over the next 25 years, equivalent to over three deaths every minute.

Related Posts
Advertisements
Market Overview
Top US Stocks
Cryptocurrency Market